Cannabinoids have long fascinated both scientists and enthusiasts for their potential health benefits and varied applications. Among these compounds, CBG (cannabigerol) has gained attention as a precursor to other well-known cannabinoids like THC and CBD. However, an emerging player in this arena is CBG9, a derivative of CBG, which shows promising therapeutic properties. This article delves into what CBG9 is, how it differs from CBG, and its potential benefits.
Key Takeaways of CBG9:
Introduction to CBG9: CBG9 is a cannabinoid derived from CBG, known for its unique therapeutic properties.
Differences from CBG: CBG9 binds more specifically to CB1 and CB2 receptors, potentially offering targeted benefits.
Health Benefits: CBG9 shows promise in similar areas as CBG does.
Usage Forms: Available in oils, tinctures, capsules, pills, topicals, and edibles.
Side Effects: Generally mild, including dry mouth, increased appetite, fatigue, and mild stomach discomfort.
Future Potential: Increased interest and ongoing research into its applications.
Market and Sustainability: Growing consumer demand for ethical and sustainable cannabinoid products.
What is CBG9?
CBG9 is the lesser-known nitrogenous analogue of cannabigerol (CBG), which is sometimes called the ‘mother of all cannabinoids’ for its ability to synthesize other cannabinoids. In plants, CBG is synthesized and metabolized into the more common cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD). CBG9 is a distinct specimen that keeps CBG’s medicinal benefits and creates something new from the old: a trend-setting, preferred molecule with different properties and impacts on its users.
Difference Between CBG and CBG9
Although CBG and CBG9 share origin from the same precursor, they seem to bind to the endocannabinoid system in different ways. Namely, CBG9 has a greater affinity for CB1 and CB2 receptors found throughout the body, which is part of the endocannabinoid system that has been shown to play a role in physiological functions.
CBG tends to exhibit what are known as broad-spectrum benefits. CBG9, on the other hand, is being explored because it seems to possess greater potency in these areas, potentially offering more targeted therapeutic effects too. The differences in their structural make-up may make one more or less bioavailable or better metabolized by the organism.
Health Benefits of CBG9
CBG9 remains in the research phase, but so far scientists have discovered a number of potential health benefits.
How to Use CBG9
CBG9 is available in several forms, which can give users a choice based on preferences and needs Some of these forms include:
- Oils and Tinctures: Consumers have been drawn to a sublingual and food-grade form of dosing, which is simple and easy to control – simply take it under the tongue or incorporate into food and drink.
- Capsules and Pills: These offer a convenient way to consume CBG9, ensuring consistent dosages.
- Topicals: CBG9-infused creams and balms can be applied directly to the skin.
- Edibles: Another option is to ingest CBG9 when it is found in edible goods, your own creation or store-bought.
Potential Side Effects
CBG9 is generally well-tolerated, with even the most sensitive men reporting occasional dry mouth, mildly increased appetite, yawning, perhaps mild fatigue, and some very mild stomach discomfort. Like any supplement, it is important to start with a very low dosage and raise it slowly, my supplier recommends increasing it by a quarter-capsule every two days until you get the right dose for you based on your body’s responses.
Future Potential and Research
As more research bears fruit, it seems CBG9 could be having a moment. Specifically, researchers are exploring its potential to be used in treating a broad range of medical conditions. Because it’s not psychoactive, it’s also a strong prospect for medical therapeutics.
Growing Interest and Market Availability
As more people begin to use cannabis for wellness and therapeutic purposes, their increased knowledge of the attributes of the different cannabinoids spurs the development and availability of these products, including different options such as CB9. In turn, this growth in interest stimulates further research and innovation to create new products for targeted needs.
Sustainability and Ethical Considerations
The cultivation and extraction of CBG9 – and other cannabinoids in general – also carry with them further questions concerning ethics and sustainability. As the market grows, producers are likely to face increasing pressure to employ sustainable cultivation techniques and procure their offerings ethically from their points of origin. Such concerns include minimizing environmental impact, using farming methods that are ‘certified organic’, and sourcing from reputable growers who treat workers and the local community according to agreed ethical standards. Consumers are increasingly cognizant of these considerations and can often be willing to pay a premium when products reflect their own values around sustainability and ethics.
Conclusion about CBG9
CBG9 may represent a completely new field in cannabinoid research, and its potential to offer health benefits is well worth considering seriously. As research progresses, we should anticipate learning more about how this unique cannabinoid can be harnessed to promote better health.
This is one of several cannabinoid agonists that can be recommended, whether you are already a user of cannabinoids or are considering cannabis-derived compounds for the first time. Always check with a healthcare professional before initiating a new supplement to make sure there are no contraindications to its use with your particular health status.
Article Sources:
Simple Leaf CBD uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. We fact-check and keep our content accurate, reliable, and trustworthy.
1. What is CBG? The minor cannabinoid with major potential explained. Journal of Cannabinoid Medicine.
2. Borrelli F, Fasolino I, Romano B, et al. Beneficial effect of the non-psychotropic plant cannabinoid Cannabigerol on experimental inflammatory bowel disease. Biochemical Pharmacology. 2013;85(9):1306-1316.
3. Colasanti BK. A comparison of the ocular and central effects of tetrahydrocannabinol and cannabigerol. Journal of Ocular Pharmacology and Therapeutics. 1990;6(4):259-269.
4. Valdeolivas S, Navarrete C, Cantarero I, Bellido ML, Muñoz E, Sagredo O. Neuroprotective properties of cannabigerol in huntington’s disease: studies in r6/2 mice and 3-nitropropionate-lesioned mice. Neurotherapeutics. 2015;12(1):185-199.
5. Farha MA, El-Halfawy OM, Gale RT, et al. Uncovering the hidden antibiotic potential of cannabis. ACS Infect Dis. 2020;6(3):338-346.
6. Orrego-González E, Londoño-Tobón L, Ardila-González J, Polania-Tovar D, Valencia-Cárdenas A, Velez-Van Meerbeke
A. Cannabinoid effects on experimental colorectal cancer models reduce aberrant crypt foci (Acf) and tumor volume: a systematic review. Evidence-Based Complementary and Alternative Medicine. 2020;2020:1-13.
